Narrative Review · White Paper
IBS-D, the Gut–Brain Axis and South India: A Narrative Review
Long-form analysis of stress, diet and non-pharmacological management in diarrhea-predominant IBS.
Why this review matters
Diarrhea-predominant irritable bowel syndrome is both common and under-discussed, particularly in South India, where stress-heavy urban lifestyles and chili-forward diets intersect. This review brings together current evidence on how the gut–brain axis, FODMAP-rich foods and TRPV1-mediated responses to capsaicin contribute to IBS-D — and where the literature is still silent for Telangana and Andhra Pradesh.
Rather than inventing regional numbers, the article is explicit about the gaps: the absence of Rome IV-based prevalence data for these states, and the lack of controlled trials for many traditional practices. For clinicians, researchers and HEOR teams, it offers a clear map of what we know, what we do not, and where future regional studies should focus.
This is a narrative (non-systematic) review intended for education and discussion. It has not undergone journal peer review. It was drafted with AI assistance; all content was researched, verified, and edited by the author, who takes responsibility for its accuracy. It is not medical advice — individuals with gastrointestinal symptoms should consult a qualified clinician.
Epidemiology at a glance
| Region | Overall IBS prevalence | Notes |
|---|---|---|
| Global | ~4–11% (varies by criteria) | Estimates vary substantially by diagnostic criteria (Rome II/III/IV) and study design. |
| Asia (pooled) | Generally lower than Western estimates | Attributed to a mix of possible true prevalence differences and symptom-reporting / cultural factors. |
| South India (Telangana / AP) | Not well characterized | No dedicated large-scale Rome IV-based prevalence study identified for this region at time of writing. |
The absence of a dedicated regional dataset is itself a finding worth stating plainly — a genuine gap, not something to paper over with unsourced estimates.
How the gut–brain axis drives symptoms
Central stress and the HPA axis
Chronic psychological stress is a well-established trigger for IBS symptom flares. Stress activates the hypothalamic–pituitary–adrenal (HPA) axis, driving release of corticotropin-releasing factor (CRF). CRF signaling through CRF1 receptors in the gut is linked to enteric mast cell activation, altered motility, and visceral hypersensitivity — one of the most consistently replicated findings in IBS research. Everyday stressors such as financial pressure or commuting anxiety are plausible examples of general life-stress, rather than findings established in any published South Indian cohort.
Diet: FODMAPs and capsaicin
High-FODMAP foods can ferment and pull fluid into the colon, contributing to bloating and loose stool in susceptible people. Capsaicin — abundant in chili-forward regional cuisine — activates TRPV1 receptors on gut sensory neurons, a plausible contributor to burning sensation and altered motility in sensitized individuals. Both mechanisms are well described in the general literature; their specific contribution within South Indian diets has not been directly quantified and is a valuable direction for future regional research.
Non-pharmacological management: evidence vs. tradition
| Approach | Evidence status | Plausible mechanism |
|---|---|---|
| Mind–body therapy (meditation, breathing) | Reasonably supported for IBS generally | Downregulation of the sympathetic stress response |
| Probiotics | Mixed; strain-specific — some help, some don't | Modulation of gut microbiota |
| Polyphenol-rich foods (e.g. pomegranate) | Preliminary / limited in IBS-D specifically | Proposed effects on gut barrier integrity |
| Traditional dietary practices (buttermilk, herbal preparations) | Traditional / anecdotal — not established by controlled trials | Unclear; plausible but unproven |
The honest distinction matters: mind–body therapy and select probiotic strains have a real evidence base. Traditional practices common in South Indian households may genuinely help some individuals, but they should be described as practices worth further study — not as clinically proven protocols.
Where the research needs to go
The mechanistic case for a gut–brain axis contribution to IBS-D is well supported. What's genuinely missing is dedicated epidemiological and interventional research in South Indian populations — ideally a registered cross-sectional or cohort study using Rome IV criteria in Telangana and Andhra Pradesh clinical settings, and controlled evaluation of the traditional practices patients already use.
Work with me on HEOR, medical writing & reviews
I apply the same disciplined, transparent approach shown in this review to client projects in gastroenterology, internal medicine and pharmacy — turning complex evidence into clear, publication-ready documents.
Medical & scientific writing
- Narrative and systematic reviews
- Journal-ready manuscripts and revisions
- Clinical and mechanistic overviews for education or market access
HEOR & evidence synthesis
- Burden-of-illness and epidemiology narratives
- Non-pharmacological and integrative-care evidence summaries
- Methodologically transparent use of AI tools for literature mapping
PhD & early-career mentorship
- Protocol design, research methodology and statistics
- Publication strategy and journal targeting
- Training in the ethical use of generative AI for research and writing
References
- Drossman DA, Hasler WL. Rome IV—Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology. 2016;150(6):1257-1261.
- Gwee KA, Ghoshal UC, Chen M. Irritable bowel syndrome in Asia: pathogenesis, natural history, epidemiology, and management. J Gastroenterol Hepatol. 2018;33:99-110.
- Taché Y, Martinez V, Million M, Maillot C. Role of corticotropin releasing factor receptor subtype 1 in stress-related functional colonic alterations: implications in irritable bowel syndrome. Eur J Surg Suppl. 2002;(587):16-22.
- Sperber AD. Epidemiology and burden of irritable bowel syndrome: an international perspective. Gastroenterol Clin North Am. 2021;50(3):489-503.